跳至主要内容
临床试验/NCT06334549
NCT06334549招募中4 期

Effects of Vasopressor on Cerebral Oxygenation During General Anesthesia in Abdominal Surgery

Dalian Municipal Central Hospital1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2024年3月5日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
180
试验地点
1
主要终点
Continual changes in Cerebral Oxygen Saturation

研究概览

简要总结

The purpose of this study is to investigate whether norepinephrine(N), phenylephrine(P) or ephedrine(E) have different effect on cerebral oxygenation in abdominal surgery with propofol or sevoflurane.

详细描述

This study was a single-center, randomized, double-blinded, controlled trial. First, the effects of E, P, or N on cerebral oxygen saturation(rScO2) under general anesthesia in abdominal surgery were studied. Patients with abdominal surgery were evaluated using near-infrared spectroscopy. Continual changes in systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial blood pressure (MAP), heart rate (HR), stroke volume (SV), cardiac output (CO) and systemic vascular resistance (SVR) will be measured with LiDCO rapidV3 monitoring system. To investigate the individualized therapeutic options & specific mechanisms of the three vasopressors on rScO2 and CO.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA I-III, age 18-80 years
  • Elective abdominal surgery
  • Signed informed consent

排除标准

  • Preoperative unstable blood hemodynamics
  • Allergy to ephedrine, phenylephrine or norepinephrine
  • Decrease in MAP <20%
  • Severe cardiovascular disorder

研究组 & 干预措施

Ephedrine-Propofol

Experimental

receive ephedrine 0.15mg/kg (configured concentration 6mg/mL) when MAP was a 20% decrease in baseline blood pressure after both induction of anesthesia and tracheal intubation.

干预措施: Ephedrine-P (Drug)

Phenylephrine-propofol

Experimental

receive phenylephrine 2.5ug/kg(configured concentration 100ug/mL) when MAP was a 20% decrease in baseline blood pressure after both induction of anesthesia and tracheal intubation.

干预措施: Phenylephrine-P (Drug)

Norepinephrine-propofol

Experimental

receive norepinephrine 0.2ug/kg(configured concentration 8μg/ml) when MAP was a 20% decrease in baseline blood pressure after both induction of anesthesia and tracheal intubation.

干预措施: Norepinephrine-P (Drug)

Ephedrine-sevoflurane

Active Comparator

receive Ephedrine 0.15mg/kg(configured concentration 6mg/mL) when MAP was a 20% decrease in baseline blood pressure after both induction of anesthesia and tracheal intubation.

干预措施: Ephedrine-S (Drug)

Phenylephrine-sevoflurane

Active Comparator

receive phenylephrine 2.5ug/kg(configured concentration 80ug/mL) when MAP was a 20% decrease in baseline blood pressure after both induction of anesthesia and tracheal intubation.

干预措施: Phenylephrine-S (Drug)

Norepinephrine-sevoflurane

Active Comparator

receive norepinephrine 0.2ug/kg(configured concentration 8ug/mL) when MAP was a 20% decrease in baseline blood pressure after both induction of anesthesia and tracheal intubation.

干预措施: Norepinephrine-S (Drug)

结局指标

主要结局

Continual changes in Cerebral Oxygen Saturation

时间窗: 10 minutes after entering the operating room; when 20% decrease in baseline MAP after both induction of anesthesia and intubation; when MAP rising to the highest point after administration of vasopressors

This outcome is measured by near-infrared spectroscopy

次要结局

  • Continual changes in heart rate (HR)(10 minutes after entering the operating room; when 20% decrease in baseline MAP after both induction of anesthesia and intubation; when MAP rising to the highest point after administration of vasopressors)
  • Continual changes in cardiac output (CO)(10 minutes after entering the operating room; when 20% decrease in baseline MAP after both induction of anesthesia and intubation; when MAP rising to the highest point after administration of vasopressors)
  • Continual changes in stroke volume (SV)(10 minutes after entering the operating room; when 20% decrease in baseline MAP after both induction of anesthesia and intubation; when MAP rising to the highest point after administration of vasopressors)
  • Continual changes in systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial blood pressure (MAP)(10 minutes after entering the operating room; when 20% decrease in baseline MAP after both induction of anesthesia and intubation; when MAP rising to the highest point after administration of vasopressors)
  • Continual changes in systemic vascular resistance (SVR)(10 minutes after entering the operating room; when 20% decrease in baseline MAP after both induction of anesthesia and intubation; when MAP rising to the highest point after administration of vasopressors)

研究者

发起方
Dalian Municipal Central Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Liping Han

Professor & Vice Director

Dalian Municipal Central Hospital

研究点 (1)

Loading locations...

相似试验